Foresight Biotherapeutics - Ownership and Business Overview

Life ScienceCompany

Foresight Biotherapeutics Ownership

Who owns Foresight Biotherapeutics?

Foresight Biotherapeutics is owned by Shire. It was acquired on August 3, 2015.

Foresight Biotherapeutics Business Overview

Where is Foresight Biotherapeutics headquartered?

Foresight Biotherapeutics is headquartered in New York, New York.

What sector is Foresight Biotherapeutics in?

Foresight Biotherapeutics is a life science company.

When was Foresight Biotherapeutics founded?

Foresight Biotherapeutics was founded in 2008.

Life Science M&A Summary in 2015

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2015. The largest life science acquisition in 2015 was Allergan - which was acquired by Allergan for $70.5B.

Join Mergr to view all 293 acquisitions of life science companies in 2015, including 32 acquisitions by private equity firms, and 261 by strategics.

Foresight Biotherapeutics, Inc.

50 West 57th Street, 15th Floor,
New York, New York 10019
United States,
(646) 747-9100
www.foresightbio.com

Foresight Biotherapeutics, Inc. is a therapy in late-stage development for the treatment of infectious conjunctivitis, an ocular surface condition commonly referred to as pink eye.


 Subscribe to unlock this and 208,718
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.